We’ve updated the NF Clinical Trials section of our website via clinicaltrials.gov.
Studies that have recently been added include:
A Trial of Ganetesib Plus Sirolimus: Phase 1 Includes Multiple Sarcoma Subtypes and Phase 2 MPNST
Selumentinib in Treating Young Patients with Recurrent or Refractory Low Grade Glioma
Diagnosis of Pheochromocytoma
Auditory Brainstem Implantation in Young Children
Clinical trials are an exciting and important opportunity for people with NF1 and NF2 to make a difference in their own lives as well as the lives of others affected with NF1 and NF2. When you participate in a clinical trial or study you are:
- Receiving the most advanced care
- Giving to future generations of people living with NF1 and NF2
- Helping to change the way we practice medicine
If you are interested in learning more about the importance of participating in clinical trials or about clinical trials in general, please visit NF Clinical Trial Facts.